Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

NCT00334958 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Placebo
DRUG: Rufinamide

Sponsor

Eisai Inc.